TheStreet upgraded shares of United-Guardian, Inc. (NASDAQ:UG) from a c rating to a b rating in a research note published on Thursday morning.

Separately, ValuEngine raised United-Guardian from a sell rating to a hold rating in a report on Thursday, July 27th.

Shares of United-Guardian (NASDAQ UG) traded up 3.13% during midday trading on Thursday, reaching $17.30. 1,217 shares of the company’s stock were exchanged. The company’s 50-day moving average is $16.03 and its 200-day moving average is $15.20. The stock has a market cap of $79.48 million, a P/E ratio of 23.44 and a beta of 0.23. United-Guardian has a one year low of $13.75 and a one year high of $18.05.

United-Guardian (NASDAQ:UG) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $0.24 EPS for the quarter. The business had revenue of $3.78 million during the quarter. United-Guardian had a return on equity of 23.71% and a net margin of 26.20%.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at

An institutional investor recently raised its position in United-Guardian stock. Northern Trust Corp boosted its stake in United-Guardian, Inc. (NASDAQ:UG) by 5.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 10,763 shares of the company’s stock after buying an additional 592 shares during the period. Northern Trust Corp owned about 0.23% of United-Guardian worth $167,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 22.69% of the company’s stock.

About United-Guardian

United-Guardian, Inc manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, healthcare products and specialty industrial products. The Company also conducts research and product development, primarily related to the development of cosmetic and personal care products.

Receive News & Stock Ratings for United-Guardian Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United-Guardian Inc. and related stocks with our FREE daily email newsletter.